Finance

Beta
Lists
CTKB:NASDAQ
Cytek Biosciences Inc
$4.09
-5.54%
(-0.24) 1D
Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTKB...
Open
$4.24
High
$4.45
Low
$4.02
Mkt. cap
528.19M
Avg. vol.
939.38K
Volume
0.00
52-wk high
$6.18
52-wk low
$2.90
EPS
-$0.58
Beta
1.19
Shares outstanding
129.14M
No. of employees
678
Open
$4.24
High
$4.45
Low
$4.02
Mkt. cap
528.19M
Avg. vol.
939.38K
Volume
0.00
52-wk high
$6.18
52-wk low
$2.90
EPS
-$0.58
Beta
1.19
Shares outstanding
129.14M
No. of employees
678
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to CTKB in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CTKB in the last 3 months.
Highest
Current $4.09
$7.50 (+83.37%)
Average
$5.69 (+39.12%)
Lowest
$4.75 (+16.14%)
News stories
From sources across the web
About Cytek Biosciences Inc
CEO-
Employees678
Founded1992
Headquarters-
SectorHealth care
Websitecytekbio.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.10 / -$0.06
-47.69%miss
Revenue / Est. (USD)
44.14M / 44.30M
-0.37%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
45.60M
52.29M
62.14M
44.14M
Cost of goods sold
21.74M
24.74M
29.26M
22.88M
Cost of revenue
21.74M
24.74M
29.26M
22.88M
Research and development expenses
8.83M
8.96M
8.96M
9.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.66M
27.79M
29.52M
30.11M
Operating expense
34.49M
36.74M
38.48M
39.72M
Total operating expenses
56.23M
61.48M
67.74M
62.60M
Operating income
-10.62M
-9.19M
-5.59M
-18.46M
Other non operating income
3.71M
444.00K
1.56M
1.76M
EBT including unusual items
-6.78M
-7.77M
-4.03M
-17.37M
EBT excluding unusual items
-6.78M
-7.77M
-4.03M
-17.37M
Income tax expense
-1.19M
-2.29M
40.04M
1.49M
Effective tax rate
17.59%
29.49%
-993.43%
-8.59%
Other operating expenses
-
-
-
-
Net income
-5.58M
-5.48M
-44.08M
-18.87M
Net profit margin
-12.24%
-10.48%
-70.93%
-42.75%
Earnings per share
-0.01
-0.00
-0.29
-0.10
Interest and investment income
555.00K
573.00K
1.30M
787.00K
Interest expense
-414.00K
-494.00K
-
-262.00K
Net interest expenses
141.00K
79.00K
1.30M
525.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.73M
-7.27M
-3.70M
-16.60M
Gain or loss from assets sale
152.00K
102.00K
60.00K
55.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer